Jonathan Kenneth Charles Knowles
CIK: 0001662103
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CAI
Caris Life Sciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Knowles Jonathan Kenneth Charles
Knowles Jonathan Kenneth Charles (SEC CIK 0001662103) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI).
Signal8 holds 2 ownership filings by Knowles Jonathan Kenneth Charles (1 Form 3, 1 Form 4), filed between Jun 17, 2025 and Jun 2, 2026. Those filings report 1 transaction, the latest on May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Knowles Jonathan Kenneth Charles's filings is in IRVING, TX.
Recent filings by Knowles Jonathan Kenneth Charles
- May 29, 2026: Grant or award of CAI shares (Form 4, code A).
Other insiders filing for Caris Life Sciences, Inc. (CAI)
- Denton John Russel
- Brille Brian J
- Spetzler David Baxley, President
- CASTLEMAN PETER M, Director
- PHILLIPS T DANNY, Director
- Minor Lloyd, Director